Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones
Accesswire
*Innovative pro-drug delivers superior efficacy with improved drug-like properties and safety profile*
*CAMBRIDGE, MA /..